Dr. Apinya Vutikullird, DO
Claim this profileArk Clinical Research
Studies Norovirus Infection
Studies Norovirus
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
More about Apinya Vutikullird, DO
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Apinya Vutikullird, DO has experience with
- Bivalent GII.4/GI.1 Vaccine
- NVX CoV2373
Breakdown of trials Apinya Vutikullird, DO has run
Norovirus Infection
Coronavirus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Apinya Vutikullird, DO specialize in?
Apinya Vutikullird, DO focuses on Norovirus Infection and Norovirus. In particular, much of their work with Norovirus Infection has involved treating patients, or patients who are undergoing treatment.
Is Apinya Vutikullird, DO currently recruiting for clinical trials?
No, Apinya Vutikullird, DO is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Apinya Vutikullird, DO has studied deeply?
Yes, Apinya Vutikullird, DO has studied treatments such as Bivalent GII.4/GI.1 vaccine, NVX CoV2373.
What is the best way to schedule an appointment with Apinya Vutikullird, DO?
Apply for one of the trials that Apinya Vutikullird, DO is conducting.
What is the office address of Apinya Vutikullird, DO?
The office of Apinya Vutikullird, DO is located at: Ark Clinical Research, Long Beach, California 90806 United States. This is the address for their practice at the Ark Clinical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.